GSK and CureVac sign mRNA vaccine and therapy deal
Thursday, July 23, 2020 - 17:36
in Health & Medicine
Investment of about $300 million up front is latest vote of confidence in mRNA technology
Investment of about $300 million up front is latest vote of confidence in mRNA technology